BETA-AMYLOID PROTEIN - ANVISA Registration 10230730201

Access comprehensive regulatory information for BETA-AMYLOID PROTEIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10230730201 and manufactured by NL COMÉRCIO EXTERIOR LTDA. The registration is held by NL COMÉRCIO EXTERIOR LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including FUJIREBIO EUROPE N.V., EUROIMMUN AG, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.